Hemostasis Instruments

HUMAN offers integrated hemostasis testing solutions that combine HEMOSTAT reagents with HumaClot analyzers, available in both semi-automated and fully automated formats. These systems are designed for precise and economical evaluation of coagulation status, with pre-programmed and validated applications for a wide range of commonly performed screening parameters. Key tests include Prothrombin Time (PT) for monitoring oral anticoagulant therapy, activated Partial Thromboplastin Time (aPTT) for detecting Hemophilia and monitoring heparin therapy, as well as D-dimer, functional fibrinogen, and thrombin time.

In addition to these core coagulation tests, HUMAN’s portfolio includes advanced diagnostics for thrombophilia, such as antithrombin and free Protein S assays, essential for assessing thrombotic risk. The D-dimer test also serves as an indicator for the progression of inflammatory diseases like COVID-19, making HUMAN’s hemostasis solutions comprehensive and vital for effective patient care.